| December 6, 2017 |
Webinar: Application of β-Arrestin Assays to the Orphan GPCR World - 30 min.
What will be covered?
- How PathHunter services save development time compared to in-house assays
- Screening and profiling biologics with highly specific and sensitive assays that produce robust and reproducible results
- Example data from marketed drugs, like Pembrolizumab and Nivolumab, using these cell-based assays
|
Login to view
|
Login to view
|
| August 16, 2017 |
Webinar: Discovery of Bacterial Effectors in the Human Microbiome and Isolation of a GPCR G2A/GPR132 Agonist - 30 min.
What will be covered?
- The role of GPCRs in regulating host-microbial interactions
- How to identify microbial metabolites that modulate GPCR functions
- A case study on defining host-microbial interaction and therapeutic potential of N-acyl amides, bacterial metabolites that activate GPR132/G2A
|
Login to view
|
Login to view
|
| April 5, 2017 |
Webinar: From Chemistry to Clinic: Discovery of Biased Apelin Receptor Agonists and Action in the Cardiovascular System - 55 min.
What will be covered?
- Role of GPCRs in human cardiovascular system
- Strategies for exploiting orphan GPCRs recently paired with endogenous ligands illustrated by Apelin and Elabela/Toddler
- Identifying biased agonists using pharmacologically-relevant functional cell based assays
- Validating assays and minimizing inter-assay variation
|
Login to view
|
Login to view
|
| March 9, 2017 |
Webinar: Mu Opioid Receptor Splicing and Signaling: Another Dimension of GPCR Function - 55 min.
What will be covered?
- Overview of the mu opioid receptor signaling
- GPCR splicing, using OPRM1 as an example
- Region and cell specific splicing
- Functional consequences of 5’ splicing
- Functional consequences of 3’ splicing
|
Login to view
|
Login to view
|
| February 1, 2017 |
Webinar: Unlocking GPCRs for Oncology - 35 min.
What will be covered?
- Opportunities and challenges for targeting GPCRs in oncology
- Examples of GPCR-targeting investigational therapies for oncology
- Imipridones, selective GPCR-targeting small molecules, that are in preclinical and clinical development for oncology
|
Login to view
|
Login to view
|
| November 9, 2016 |
Webinar: Duplexed Screening of GPCRs to Measure Calcium and β-Arrestin - 60 min.
What will be covered?
- Screening approaches for GPCR drug discovery
- Creating a duplexed assay to monitor calcium and β-arrestin in a single well
- Determine potential bias for various drugs and define potency ranking
|
Login to view
|
Login to view
|